FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Astellas Files NDA for Vasomotor Symptom Therapy

[ Price : $8.95]

FDA accepts for priority review an Astellas Pharma NDA for fezolinetant, a nonhormonal compound for treating moderate to severe va...

FDA Warning on Retractable Needles

[ Price : $8.95]

FDA warns about the potential for needle stick injuries from recently recalled Haiou Needle Retractable Safety 1 mL syringe with 2...

Fall Covid Boosters on Fast Track with Mouse Data

[ Price : $8.95]

FDA is permitting Covid-19 vaccine makers to submit mouse data to expedite authorization of their omicron-protecting vaccine boost...

Final Rule on OTC Hearing Aids

[ Price : $8.95]

Federal Register final rule: FDA establishes a regulatory category for over-the-counter hearing aids and making related amendments...

Respironics Ventilator MDRs Increase

[ Price : $8.95]

FDA says it has received 168 reports of deaths in more than 69,000 medical device reports associated with PE-PUR foam degradation ...

Preceptis Device Cleared for Ear Tube Procedures

[ Price : $8.95]

FDA clears a Preceptis Medical 510(k) for expanded indications for its Hummingbird Tympanostomy Tube System for office-based pedia...

Gene Therapy OKd for Blood Disorder

[ Price : $8.95]

FDA approves the first cell-based gene therapy for treating adult and pediatric patients with beta-thalassemia who require regular...

FDA Cybersecurity 2022 Guidance Explained

[ Price : $8.95]

Attorney Brynn Stanley outlines provisions in a 2022 FDA draft cybersecurity guidance and how they differ from the 2018 draft it r...

Brainstorm to File BLA for Lou Gehrigs Disease

[ Price : $8.95]

Brainstorm Cell Therapeutics says it will submit a BLA for it NurOwn stem cell therapy for treating amyotrophic lateral sclerosis.

Califf on New Ecosystem to Fight Disinformation

[ Price : $8.95]

FDA commissioner Robert Califf tells FDA Webview his agency is joining with other entities, especially universities, to form a new...